Rates and correlates of nonadherence to treatment in obsessive-compulsive disorder

Journal of Psychiatric Practice

Volumn 19, Issue 1, 2013, Pages 42-53

  Santana, Lívia ^a   Fontenelle, Júlia M ^a   Yücel, Murat ^b   Fontenelle, Leonardo F ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

aggressive violent obsessions; cognitive behavioral therapy; hoarding; insight; medication adherence; obsessive compulsive disorder

Indexed keywords

ANXIOLYTIC AGENT;

ADULT; AGITATION; ALCOHOLISM; ARTICLE; BECK DEPRESSION INVENTORY; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BROWN ASSESSMENT OF BELIEFS SCALE; COGNITIVE THERAPY; CONSTIPATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION INVENTORY; DIARRHEA; DISABILITY; DISEASE SEVERITY; DYSTHYMIA; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; GENERALIZED ANXIETY DISORDER; HEADACHE; HUMAN; INTELLIGENCE; INTELLIGENCE QUOTIENT; LIBIDO DISORDER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW 6.0; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NERVOUSNESS; OBSESSIVE COMPULSIVE DISORDER; OBSESSIVE HOARDING; PANIC; PATIENT COMPLIANCE; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGIC TEST; PSYCHOSIS; SHEEHAN DISABILITY SCALE; SOCIAL PHOBIA; TEST RETEST RELIABILITY; TREATMENT ADHERENCE SURVEY PATIENT VERSION; TREATMENT REFUSAL; WECHSLER ABBREVIATED SCALE OF INTELLIGENCE; WEIGHT GAIN; XEROSTOMIA; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

ADULT; COGNITIVE THERAPY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MEDICATION ADHERENCE; OBSESSIVE-COMPULSIVE DISORDER; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS; PSYCHOTROPIC DRUGS; WECHSLER SCALES;

EID: 84873862277     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000426326.49396.97     Document Type: Article

References (35)

1. Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:327-37
2. DuPont RL, Rice DP, Shiraki S, et al. Economic costs of obsessive-compulsive disorder. Med Interface 1995;8: 102-9
3. Collins PY, Patel V, Joestl SS, et al. Grand challenges in global mental health. Nature 2011;475:27-30
4. Jenike MA. Drug treatment of obsessive-compulsive disorders. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive-compulsive disorders: Practical management, third edition. St. Louis: Mosby; 1998:469-532
5. Denys D. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Psychiatr Clin North Am 2006;29:553-84
6. Fontenelle LF, de Menezes GB, Versiani M. Patients with obsessive-compulsive disorder may only respond to the fifth drug trial. Presentation at the 19th Brazilian Congress of Psychiatry. Recife, Brazil; 2001
7. Santana L, Fontenelle LF. A review of studies concerning treatment adherence of patients with anxiety disorders. Patient Prefer Adherence 2011;5:427-39
8. Mancebo MC, Pinto A, Rasmussen SA, et al. Development of the Treatment Adherence Survey-Patient Version (TASP) for OCD. J Anxiety Disord 2008;22:32-43
9. Hansen AM, Hoogduin CA, Schaap C, et al. Do drop-outs differ from successfully treated obsessive-compulsives? Behav Res Ther 1992;30:547-50
10. Diniz JB, Malavazzi DM, Fossaluza V, et al. Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder. Clinics (Sao Paulo) ;66:387-93
11. Mancebo MC, Eisen JL, Sibrava NJ, et al. Patient utilization of cognitive-behavioral therapy for OCD. Behav Ther 2011;42:399-412
12. Maher MJ, Wang Y, Zuckoff A, et al. Predictors of patient adherence to cognitive-behavioral therapy for obsessivecompulsive disorder. Psychother Psychosom 2012;81: 124-6
13. Mataix-Cols D, Marks IM, Greist JH, et al. Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: Results from a controlled trial. Psychother Psychosom 2002;71:255-62
14. Timpano KR, Exner C, Glaesmer H, et al. The epidemiology of the proposed DSM-5 hoarding disorder: Exploration of the acquisition specifier, associated features, and distress. J Clin Psychiatry 2011;72:780-6; quiz 878-9
15. Moritz S, Kloss M, Jacobsen D, et al. Neurocognitive impairment does not predict treatment outcome in obsessive- compulsive disorder. Behav Res Ther 2005;43:811-9
16. Fontenelle JM, Santana S, Lessa R, et al. The concept of insight in patients with obsessive-compulsive disorder. Rev Bras Psiquiatr 2010;32:77-82
17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text revision. Washington, DC: American Psychiatric Association; 2000
18. Amorim P. Mini International Neuropsychiatric Interview (MINI): Validation of a short structured diagnostic psychiatric interview. Rev Bras Psiquiatri 2000;22:106-15
19. Rosario-Campos MC, Miguel EC, Quatrano S, et al. The dimensional Yale-Brown obsessive-compulsive scale (DYBOCS): An instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry 2006;11:495-504
20. Cunha JA. Manual da versão em português das Escalas Beck. São Paulo, SP2001
21. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol 1996;11: 89-95
22. Eisen JL, Phillips KA, Baer L, et al. The Brown Assess - ment of Beliefs Scale: Reliability and validity. Am J Psychiatry 1998;155:102-8
23. Yates DB, Trentini CM, Tosi SD, et al. Apresentação da Escala de Inteligência Wechsler Abreviada (WASI). Avaliação Psicológica 2006;5:227-33
24. Blumenthal R, Endicott J. Barriers to seeking treatment for major depression. Depress Anxiety 1996;4:273-8
25. Rachman S. Treating religious, sexual, and aggressive obsessions. In: Antony MM, Purdon C, Summerfeldt LJ, eds. Psychological treatment of obsessive-compulsive disorder. Washington, DC: American Psychological Association; 2007:209-99
26. Simonds LM, Thorpe SJ. Attitudes toward obsessive-com- pulsive disorders - An experimental investigation. Soc Psychiatry Psychiatr Epidemiol 2003;38:331-6
27. Salkovskis PM. Obsessions, compulsions and intrusive cognitions. In: Peck DF, Shapiro CM, eds. Measuring human problems: A practical guide. Chichester: Wiley; 1990:91-118
28. Storch EA, Merlo LJ, Larson MJ, et al. Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorder. Acta Psychiatr Scand 2008;117:67-75
29. Landeros-Weisenberger A, Bloch MH, Kelmendi B, et al. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. J Affect Disord 2010;121:175-9
30. Demet MM, Deveci A, Taskin EO, et al. Risk factors for delaying treatment seeking in obsessive-compulsive disorder. Compr Psychiatry 2010;51:480-5
31. Alonso P, Menchon JM, Jimenez S, et al. Personality dimensions in obsessive-compulsive disorder: Relation to clinical variables. Psychiatry Res 2008;157:159-68
32. Pertusa A, Mataix-Cols D. Structured interview for hoarding disorder. International OCD Foundation; 2010 (available at www.ocfoundation.org/ uploadedFiles/Hoarding /Research/SIHD%20-%20August%202010.pdf, accessed November 11, 2012).
33. American Psychiatric Association. Proposed criteria for hoarding disorder, DSM-5 development website (available at www.dsm5.org/ ProposedRevisions/Pages/proposedrevision. aspx?rid=398, accessed November11, 2012).
34. Torres AR, Fontenelle LF, Ferrao YA, et al. Clinical features of obsessive-compulsive disorder with hoarding symptoms: A multicenter study. J Psychiatr Res 2012;46:724-32
35. Chen PY, Wang SC, Poland RE, et al. Biological variations in depression and anxiety between East and West. CNS Neurosci Ther 2009;15:283-94